International Clinical Neuroscience Journal

Vol. 8 No. 4 (2021)

Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report Migraine and Multiple Sclerosis

International Clinical Neuroscience Journal, Vol. 8 No. 4 (2021), 30 October 2021 , Page 208-211

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease, causing neuronal demyelination and axonal damage in the central nervous system. Symptoms of MS vary widely because of different grades of sensory, motor, and cognitive dysfunctions. Although headache as the initial symptom of MS is rare, it is a common comorbidity that affects most patients. However, it is unclear that the headache manifestation in newly diagnosed people with MS should be considered as an MS attack or merely a comorbid condition. We report the case of a 31-year-old woman with newly diagnosed MS who presented with exacerbation of headache episodes without any abnormal neurological exam findings. The headaches did not respond to nonsteroidal anti-inflammatory drugs and triptans. After administration of methylprednisolone, the headaches were significantly improved, and during 3 months of follow-up receiving glatiramer acetate, no episode of headache has occurred. This case demonstrates the possible relationship between migraine and MS in newly diagnosed patients. New-onset headaches, a change in the pattern of previous episodes, and inadequate clinical drug response to headache treatment should all be taken seriously and warrant further investigation. Thereby, early diagnosis and proper treatment for patients with MS could improve their quality of life.

Keywords:
  • Migraine disorders
  • Headache
  • Multiple sclerosis
  • Treatment outcome

How to Cite

1.
Rabiei MM, Cheraghi Z, Ramezani M, Pakdaman H. Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report: Migraine and Multiple Sclerosis. Int Clin Neurosci J [Internet]. 2021 Oct. 30 [cited 2023 Nov. 29];8(4):208-11. Available from: https://journals.sbmu.ac.ir/neuroscience/article/view/35542

References

Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur J Neurol. 2019;26(1):27-40. doi: 10.1111/ene.13819.

Wang L, Zhang J, Deng ZR, Zu MD, Wang Y. The epidemiology of primary headaches in patients with multiple sclerosis. Brain Behav. 2021;11(1):e01830. doi: 10.1002/brb3.1830.

Moreno-Torres I, Sabín-Muñoz J, García-Merino A. Multiple sclerosis: epidemiology, genetics, symptoms, and unmet needs. In: Martinez A, ed. Emerging Drugs and Targets for Multiple Sclerosis. Cambridge: Royal Society of Chemistry; 2019. p. 1-32.

Samkoff LM, Goodman AD. Symptomatic management in multiple sclerosis. Neurol Clin. 2011;29(2):449-63. doi: 10.1016/j.ncl.2011.01.008.

Graziano E, Hagemeier J, Weinstock-Guttman B, Ramasamy DP, Zivadinov R. Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients. Neuroimage Clin. 2015;9:110-6. doi: 10.1016/j.nicl.2015.07.013.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202.

Husain F, Pardo G, Rabadi M. Headache and its management in patients with multiple sclerosis. Curr Treat Options Neurol. 2018;20(4):10. doi: 10.1007/s11940-018- 0495-4.

Gebhardt M, Kropp P, Hoffmann F, Zettl UK. Headache at the time of first symptom manifestation of multiple sclerosis: a prospective, longitudinal study. Eur Neurol. 2018;80(3-4):115-20. doi: 10.1159/000494092.

Putzki N, Katsarava Z. Headache in multiple sclerosis. Curr Pain Headache Rep. 2010;14(4):316-20. doi: 10.1007/ s11916-010-0126-6.

La Mantia L, Prone V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015;36 Suppl 1:75-8. doi: 10.1007/s10072-015-2146-9.

Mariotti P, Nociti V, Cianfoni A, Stefanini C, De Rose P, Martinelli D, et al. Migraine-like headache and status migrainosus as attacks of multiple sclerosis in a child. Pediatrics. 2010;126(2):e459-64. doi: 10.1542/peds.2009- 2098.

Lin GY, Wang CW, Chiang TT, Peng GS, Yang FC. Multiple sclerosis presenting initially with a worsening of migraine symptoms. J Headache Pain. 2013;14(1):70. doi: 10.1186/1129-2377-14-70.

Yetimalar Y, Seçil Y, Inceoglu AK, Eren S, Başoğlu M. Unusual primary manifestations of multiple sclerosis. N Z Med J. 2008;121(1277):47-59.

Alroughani R, Ahmed SF, Khan R, Al-Hashel J. Status migrainosus as an initial presentation of multiple sclerosis. Springerplus. 2015;4:28. doi: 10.1186/s40064-015-0818-9.

Levy D. Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep. 2009;13(3):237-40. doi: 10.1007/s11916-009-0040-y.

Kister I, Caminero AB, Herbert J, Lipton RB. Tension-type headache and migraine in multiple sclerosis. Curr Pain Headache Rep. 2010;14(6):441-8. doi: 10.1007/s11916-010- 0143-5.

Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010;68(4):477-93. doi: 10.1002/ana.22230.

Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(Pt 4):1089-104. doi: 10.1093/brain/awm038.

Möhrke J, Kropp P, Zettl UK. Headaches in multiple sclerosis patients might imply an inflammatorial process. PLoS One. 2013;8(8):e69570. doi: 10.1371/journal. pone.0069570.

Klein M, Woehrl B, Zeller G, Straube A. Stabbing headache as a sign of relapses in multiple sclerosis. Headache. 2013;53(7):1159-61. doi: 10.1111/head.12138.

Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV. Meta-analysis of the relationship between multiple sclerosis and migraine. PLoS One. 2012;7(9):e45295. doi: 10.1371/journal.pone.0045295.

Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci. 2006;244(1-2):137-41. doi: 10.1016/j. jns.2006.01.015.

Johns P. Sensory and motor pathways. In: Johns P, ed. Clinical Neuroscience. Churchill Livingstone; 2014. p. 49- 59. doi: 10.1016/b978-0-443-10321-6.00004-7.

Lapucci C, Saitta L, Bommarito G, Sormani MP, Pardini M, Bonzano L, et al. How much do periventricular lesions assist in distinguishing migraine with aura from CIS? Neurology. 2019;92(15):e1739-e44. doi: 10.1212/ wnl.0000000000007266.

Paemeleire K. Brain lesions and cerebral functional impairment in migraine patients. J Neurol Sci. 2009;283(1- 2):134-6. doi: 10.1016/j.jns.2009.02.333.

  • Abstract Viewed: 136 times
  • PDF Downloaded: 206 times

Download Statastics